Jefferies raised the firm’s price target on Labcorp (LH) to $290 from $275 and keeps a Buy rating on the shares. Q4 revenues and EPS were above expectations, while FY25 guide was above on the top-line and EPS bracketed expectations, notes the analyst. The firm views the stock as attractive with the diagnostics business providing insulation from “broader healthcare noise,” the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH: